Is aspirin useful in primary cardiovascular prevention?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18497277
Cited by: 0

Abstract

Aspirin is not routinely recommended for primary prevention of cardiovascular disease due to potential bleeding risks outweighing benefits in most cases. Current guidelines suggest personalizing decisions based on individual bleeding and cardiovascular risk profiles.

Fields of Study & Subjects

Antiplatelet Therapy and Cardiovascular Diseases Inflammatory mediators and NSAID effects Lipoproteins and Cardiovascular Health

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
5 February 2026